The dynamic duo for antibody discovery. Simply the best combined wet lab + in silico antibody discovery.
Recently ranked by one of the pharmaceutical industry’s most trusted independent market research sources with the highest score for its antibody service portfolio1, the company is comprised of a hybrid of disruptive technologies and leading-edge platforms for biotherapeutic drug discovery. IPA provides highly specialized, full-continuum therapeutic antibody discovery and development, with in silico machine intelligence designed to solve the unique challenges big data processing poses pharmaceutical companies.
